Quick Answers: The Shock of an AML Diagnosis

“Quick Answers: The Shock of an AML Diagnosis” is a 9-part podcast series that features renowned acute myeloid leukemia doctors and experts. They will cover everything new patients need to know, including an explanation of what to expect after being diagnosed, the types of treatment that are available today, advice for telling your loved ones about your diagnosis and how to build a medical team that is right for you.

What Should Myeloma Patients Know About Palliative Care? 04/18/2022

What Should Myeloma Patients Know About Palliative Care? As a patient with or a care partner, you may have heard of palliative care. But what exactly is it? In the final segment of our four-part Quick Answers for Myeloma Patients podcast series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, breaks down the common misconceptions about palliative care and explains how patients can benefit from better understanding and embracing it. /episode/index/show/patientpower/id/22827398

Who Should Consider a Stem Cell Transplant for Multiple Myeloma? 04/18/2022

Who Should Consider a Stem Cell Transplant for Multiple Myeloma? How do you know when it is time to consider a stem cell transplant as a treatment for ? How does an expert weigh the pros and cons of this intense procedure? In part three of this four-part series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, talks to Patient Power writer Youssef Rddad about what factors play into decision-making for stem cell transplants. /episode/index/show/patientpower/id/22827365

Doctor Explains the Symptoms of Multiple Myeloma Relapse 04/18/2022

Doctor Explains the Symptoms of Multiple Myeloma Relapse There’s a reason myeloma patients and doctors talk about the “remission/relapse cycle.” In the second installment of our four-part podcast series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, talks to Patient Power writer Youssef Rddad about the initial symptoms of relapse and the remission/relapse cycle. Dr. Richter also discusses potential treatments for patients who have relapsed. /episode/index/show/patientpower/id/22827329

How Will My Newly Diagnosed Myeloma Be Treated? 04/18/2022

How Will My Newly Diagnosed Myeloma Be Treated? One of the first questions that pops into each patient and caregiver’s mind after a diagnosis is: “How will we treat this?” In part one of this four-part podcast series, Joshua Richter, MD, associate professor of medicine at the Tisch Cancer Institute, Mount Sinai School of Medicine, talks to Patient Power writer Youssef Rddad about first-line treatment options for newly diagnosed patients. Dr. Richter explains how often a patient may need to receive treatment and how they can expect to feel during the process. /episode/index/show/patientpower/id/22827302

What Are Reasonable Expectations for My Future? 05/01/2021

What Are Reasonable Expectations for My Future? In the ninth episode of a nine-part podcast series, Dr. Thomas LeBlanc, MD, Leukemia Specialist and Patient Experience Researcher at Duke University School of Medicine, emphasizes the importance of focusing on the goal that's right in front of you: remission. For some AML patients remission and a cure are likely outcomes; for others, disease control and a focus on prolonging and maintaining the quality of life is the path forward. /episode/index/show/patientpower/id/18933839

What Financial Support Options Exist for AML Patients? 05/01/2021

What Financial Support Options Exist for AML Patients? In the eighth episode of a nine-part podcast series, Dr. Thomas LeBlanc, MD, Leukemia Specialist and Patient Experience Researcher at Duke University School of Medicine, discusses the resources available to help AML patients navigate what can be a very complicated financial process. There is often a support person who specializes in patient financial services, and there are several programs to help offset out-of-pocket costs for medications and treatments. /episode/index/show/patientpower/id/18933824

How is Life Going to Change? 05/01/2021

How is Life Going to Change? In the seventh episode of a nine-part podcast series, Dr. Thomas LeBlanc, MD, Leukemia Specialist and Patient Experience Researcher at Duke University School of Medicine, highlights "that there will be many unexpected, unpredictable things, and you have to sort of roll with it." When first diagnosed, an AML patient often loses significant control over how they spend their time, which can affect their work, hobbies and social life. /episode/index/show/patientpower/id/18933818

How Can I Access Support During Treatment? 05/01/2021

How Can I Access Support During Treatment? In the sixth episode of a nine-part podcast series, Dr. Daniel Pollyea, MD, Clinical Director of Leukemia Services at the University of Colorado, discusses the importance of a support team during acute myeloid leukemia (AML) treatment. It is important to reach out to your medical team with any concerns you have, and it is equally important to communicate with your friends, family and loved ones to access help when it is needed. /episode/index/show/patientpower/id/18933815

What Can I Expect During Treatment? 05/01/2021

What Can I Expect During Treatment? In the fifth episode of a nine-part podcast series, Dr. Daniel Pollyea, MD, Clinical Director of Leukemia Services at the University of Colorado, discusses beginning acute myeloid leukemia treatment and how important it is for AML patients and care partners to be educated on the time commitment, decision-making process, and possible treatment side effects that accompany AML therapy. /episode/index/show/patientpower/id/18933800

What Are the Treatment Options for AML? 05/01/2021

What Are the Treatment Options for AML? In the fourth episode of a nine-part podcast series, Dr. Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, guides newly diagnosed acute myeloid leukemia patients through the different AML treatment options that are available to them. Dr. Wang explains how a patient's age, fitness, AML subtype, finances and personal preferences can inform the treatment decision. /episode/index/show/patientpower/id/18933782

When Should an AML Specialist Be Consulted? 05/01/2021

When Should an AML Specialist Be Consulted? In the third episode of a nine-part podcast series, Dr. Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, encourages newly diagnosed acute myeloid leukemia (AML) patients to add an AML specialist to their medical team. /episode/index/show/patientpower/id/18933779

Is All AML the Same? 05/01/2021

Is All AML the Same? In the second episode of a nine-part podcast series, Dr. Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center and AML specialist, explains the importance of testing at the time of diagnosis so that AML patients can determine their subtype and assure that any genetic mutations are taken into account during treatment. /episode/index/show/patientpower/id/18933767

What Is AML? The Shock of Diagnosis 05/01/2021

What Is AML? The Shock of Diagnosis In this first episode of a nine-part podcast series, Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, offers a thorough explanation of what it means to be diagnosed with acute myeloid leukemia (AML). Dr. Wang clarifies what is happening in your body, why there are no "stages" with blood cancers, and why an AML patient and their care partner should be hopeful, despite the shock of the diagnosis. /episode/index/show/patientpower/id/18933743

Quick Answers: The Shock of an AML Diagnosis

TOPICS